Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in IMVT — Immunovant, Inc.

CIK 1423053 MIAMI, FL
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$6,169,539
+$2,582,693 QoQ
Shares Held
160,123
+10.9% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 226 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Derivatives in IMVT

reported options exposure · as of Jun 30, 2026
CallValue
$2,227,034
CallShares
57,800
PutValue
$2,596,922
PutShares
67,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. IMVT ranks #123 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in IMVT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,227,034 57,800
2026-06-30 $6,169,539 160,123
2026-06-30 $2,596,922 67,400
2026-03-31 $3,586,846 144,398
2026-03-31 $439,668 17,700
2026-03-31 $1,371,168 55,200
2025-12-31 $3,927,567 154,507
2025-12-31 $2,470,824 97,200
2025-12-31 $1,494,696 58,800
2025-09-30 $1,186,432 73,600
2025-09-30 $1,460,472 90,600
2025-09-30 $12,034,434 746,553
2025-06-30 $1,075,200 67,200
2025-06-30 $5,606,272 350,392
2025-06-30 $1,088,000 68,000
2025-03-31 $5,602,529 327,825
2025-03-31 $2,529,320 148,000
2025-03-31 $1,394,544 81,600
2024-12-31 $3,777,425 152,500
2024-12-31 $3,044,233 122,900
2024-12-31 $10,998,201 444,013
2024-09-30 $2,443,307 85,700
2024-09-30 $2,813,937 98,700
2024-09-30 $9,691,147 339,921
2024-06-30 $1,562,880 59,200
2024-06-30 $1,964,160 74,400
2024-06-30 $9,068,716 343,512
2024-03-31 $2,594,493 80,300
2024-03-31 $768,978 23,800
2024-03-31 $7,382,802 228,499
2023-12-31 $34,185,925 811,439
2023-12-31 $8,691,419 206,300
2023-12-31 $1,049,037 24,900
2023-09-30 $32,453,984 845,376
2023-09-30 $10,491,987 273,300
2023-09-30 $4,921,598 128,200
2023-06-30 $5,801,955 305,849
2023-06-30 $231,434 12,200
2023-06-30 $2,122,743 111,900
2023-03-31 $2,028,708 130,800
2023-03-31 $175,263 11,300
2023-03-31 $18,082,735 1,165,876
2022-12-31 $17,265,815 972,722
2022-12-31 $23,075 1,300
2022-12-31 $3,434,625 193,500
2022-09-30 $396,921 71,133
2022-09-30 $732,096 131,200
2022-06-30 $892,710 228,900
2022-06-30 $429,018 110,005
2022-03-31 $1,272,259 230,900